Fortis Group Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Fortis Group Advisors's LLY Position: Q3 2026 in Review
Fortis Group Advisors reduced its Eli Lilly (LLY) stake by 2% in Q3 2026, selling an estimated $83.8K and leaving 3,400 shares worth $4.77M. The position accounts for 0.77% of the portfolio, ranked #38.
Fortis Group Advisors first reported a position in LLY in Q3 2020 and has held it in 14 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Fortis Group Advisors held 3,400 shares of Eli Lilly worth $4.77M as of Q3 2026.
- Fortis Group Advisors sold 71 Eli Lilly shares in Q3 2026, an estimated $83.8K.
- Eli Lilly made up 0.77% of Fortis Group Advisors's portfolio in Q3 2026, its #38 holding.
- Fortis Group Advisors first reported a position in Eli Lilly in Q3 2020 and has held it in 14 quarters since.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Fortis Group Advisors's 13F filing for Q3 2026, filed 6 Nov 2026.